Insulet
PODD
#2041
Rank
$10.03 B
Marketcap
$144.94
Share price
1.61%
Change (1 day)
-55.40%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): $0.46 Billion USD

According to Insulet's latest financial reports the company's current earnings are $2.90 Billion USD. In 2025 the company made an earning of $0.39 Billion USD, an increase over its 2024 earnings that were of $0.34 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.46 B17.62%
2025 $0.39 B16.3%
2024 $0.34 B36.76%
2023 $0.25 B481.9%
2022 $43.1 M-45.24%
2021 $78.7 M43.35%
2020 $54.9 M18.51%
2019 $46.32 M41.16%
2018 $32.81 M-711.95%
2017 -$5.37 Million-56.85%
2016 -$12.43 Million-79.31%
2015 -$60.09 Million63.85%
2014 -$36.68 Million31.04%
2013 -$27.99 Million-21.96%
2012 -$35.87 Million
2010 -$34.21 Million-42.38%
2009 -$59.36 Million-33.56%
2008 -$89.35 Million65.93%
2007 -$53.85 Million209.75%
2006 -$17.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.13 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$6.27 B 1,237.60%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$31.12 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-$0.21 Billion-142.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
$97.69 M-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$1.22 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA